SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001595585-19-000166
Filing Date
2019-08-09
Accepted
2019-08-09 16:08:36
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q q20630201910qdocument.htm   iXBRL 10-Q 1833842
2 EXHIBIT 31.1 exhibit311ceo302certif.htm EX-31.1 11477
3 EXHIBIT 31.2 exhibit312cfo302certif.htm EX-31.2 11485
4 EXHIBIT 32.1 exhibit321ceoandcfo906.htm EX-32.1 6792
  Complete submission text file 0001595585-19-000166.txt   6780848

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20190630.xsd EX-101.SCH 39833
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20190630_cal.xml EX-101.CAL 81060
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20190630_def.xml EX-101.DEF 178213
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20190630_lab.xml EX-101.LAB 542427
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20190630_pre.xml EX-101.PRE 317415
10 EXTRACTED XBRL INSTANCE DOCUMENT q20630201910qdocument_htm.xml XML 1143448
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38558 | Film No.: 191013039
SIC: 2834 Pharmaceutical Preparations